MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 9.19 USD -0.33% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
MiMedx Group Inc?
Write Note

Wall Street
Price Targets

MDXG Price Targets Summary
MiMedx Group Inc

Wall Street analysts forecast MDXG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDXG is 12.85 USD with a low forecast of 11.11 USD and a high forecast of 14.7 USD.

Lowest
Price Target
11.11 USD
21% Upside
Average
Price Target
12.85 USD
40% Upside
Highest
Price Target
14.7 USD
60% Upside

MDXG Last Price Targets
MiMedx Group Inc

The latest public price target was made on Nov 15, 2024 by Anthony Petrone from Mizuho Securities , who expects MDXG stock to rise by 74% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Anthony Petrone
Mizuho Securities
16 USD
Upside 74%
1 week ago
Nov 15, 2024
MiMedx Group (MDXG) PT Raised to $16 at Mizuho
StreetInsider
Ross Osborn
Cantor Fitzgerald
11 USD
Upside 20%
4 months ago
Jul 2, 2024
MiMedx initiated with an Overweight at Cantor Fitzgerald
TheFly
Brooks O'Neil
Lake Street
12 USD
Upside 31%
6 months ago
Apr 29, 2024
Proposed new LCDs likely benefit MiMedx if implemented, says Lake Street
TheFly
Anthony Petrone
Mizuho Securities
Price Target 16 USD
Upside/Downside 74%
View Source
Ross Osborn
Cantor Fitzgerald
Price Target 11 USD
Upside/Downside 20%
View Source
Brooks O'Neil
Lake Street
Price Target 12 USD
Upside/Downside 31%
View Source
MiMedx Group Inc Competitors:
Price Targets
0HS8
Caladrius Biosciences Inc
419% Upside
PSTX
Poseida Therapeutics Inc
427% Upside
PYC
PYC Therapeutics Ltd
77% Upside
MREO
Mereo Biopharma Group PLC
97% Upside
ARTV
Artiva Biotherapeutics Inc
86% Upside
ACAD
ACADIA Pharmaceuticals Inc
56% Upside
ALKS
Alkermes Plc
20% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
MiMedx Group Inc

For the last 8 years the compound annual growth rate for MiMedx Group Inc's revenue is 7%. The projected CAGR for the next 3 years is 11%.

7%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
MiMedx Group Inc

For the last 8 years the compound annual growth rate for MiMedx Group Inc's operating income is 7%. The projected CAGR for the next 3 years is 28%.

7%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-56%
Average Miss

Net Income
Forecast

Net Income Estimate
MiMedx Group Inc

For the last 8 years the compound annual growth rate for MiMedx Group Inc's net income is 6%. The projected CAGR for the next 3 years is 12%.

6%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDXG's stock price target?
Price Target
12.85 USD

According to Wall Street analysts, the average 1-year price target for MDXG is 12.85 USD with a low forecast of 11.11 USD and a high forecast of 14.7 USD.

What is MiMedx Group Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for MiMedx Group Inc's revenue is 7%. The projected CAGR for the next 3 years is 11%.

What is MiMedx Group Inc's Operating Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for MiMedx Group Inc's operating income is 7%. The projected CAGR for the next 3 years is 28%.

What is MiMedx Group Inc's Net Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for MiMedx Group Inc's net income is 6%. The projected CAGR for the next 3 years is 12%.

Back to Top